PERIDOT

PAtient ExpeRIence in Fabry Disease On VenglustaT

Summary:

A randomized, double-blind, placebo-controlled, 12-month Phase III study to evaluate the effect of Venglustat on neuropathic and abdominal pain in male and female adults with Fabry disease who are treatment-naive or untreated for at least 6 months. (Click the image to see more information)